TABLE 5.
Changes of OCT biomarkers presentation pre (baseline) and after study in whole group and by final CRT response.
| Whole group |
Group by final CRT response |
|||||
| CRT improved > 100 μm |
CRT improved ≤ 100 μm |
|||||
| Pre | After | Pre | After | Pre | After | |
| DRIL | 51/64 (79.7%) | 33/64 (51.6%)* | 20/22 (90.9%) | 10/22 (45.5%)* | 31/42 (73.8%) | 23/42 (54.8%) |
| SRF | 15/64 (23.4%) | 5/64 (7.8%)* | 10/22 (45.5%) | 0/22 (0.0%)* | 5/42 (11.9%) | 5/42 (11.9%) |
| LONLC | 20/64 (31.3%) | 7/64 (10.9%)* | 10/22 (45.5%) | 0/22 (0.0%)* | 10/42 (23.8%) | 7/42 (16.7%) |
| IRC | 53/64 (82.8%) | 42/64 (65.6%)* | 21/22 (95.5%) | 16/22 (72.7%)* | 32/42 (76.2%) | 26/42 (61.9%) |
| EZD | 34/64 (53.1%) | 25/64 (39.1%) | 17/22 (77.3%) | 10/22 (45.5%)* | 17/42 (40.5%) | 15/42 (35.7%) |
*p < 0.05, compared to pre-study, by Chi-Square test.